Skip to main content

Peer Review reports

From: Inosine pranobex is safe and effective for the treatment of subjects with confirmed acute respiratory viral infections: analysis and subgroup analysis from a Phase 4, randomised, placebo-controlled, double-blind study

Original Submission
26 Feb 2016 Submitted Original manuscript
Author responded Author comments
Reviewed Reviewer Report
Resubmission - Version 2
Submitted Manuscript version 2
Author responded Author comments
Resubmission - Version 3
Submitted Manuscript version 3
Author responded Author comments
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
25 Oct 2016 Editorially accepted
7 Nov 2016 Article published 10.1186/s12879-016-1965-5

You can find further information about peer review here.

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us